Naltrexone and Varenicline: Weight Gain and Tolerability in Cigarette Smokers
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the combination of naltrexone (Depade) and
varenicline (Chantix) minimizes post-smoking cessation weight gain and how well the
combination is tolerated.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Yale University
Collaborators:
National Institute on Alcohol Abuse and Alcoholism (NIAAA) National Institute on Drug Abuse (NIDA)